https://thebiotechtimes.com/daily1.0 https://thebiotechtimes.com/biologics/mbx-biosciences-doses-first-patient-phase-3-canvuparatide-trial2026-09-01T18:00Zyearly0.7 https://thebiotechtimes.com/regulatory-science/nicox-ncx-470-glaucoma-nda-accepted-april-2027-pdufa-date2026-09-01T20:00Zyearly0.7 https://thebiotechtimes.com/biologics/pfizer-and-biontech-win-fda-approval-xfg-adapted-comirnaty2026-09-02T14:00Zyearly0.7 https://thebiotechtimes.com/biologics/priovant-wins-fda-approval-brepocitinib-dermatomyositis2026-09-02T16:00Zyearly0.7 https://thebiotechtimes.com/biologics/roivants-brepocitinib-wins-fda-approval-dermatomyositis2026-09-02T20:00Zyearly0.7 https://thebiotechtimes.com/diagnostics/verrica-completes-cove-2-enrolment-ycanth-common-warts-label2026-09-03T14:00Zyearly0.7 https://thebiotechtimes.com/regulatory-science/fda-grants-zyn-nicotine-pouches-modified-risk-tobacco-status2026-08-29T17:39Zyearly0.7 https://thebiotechtimes.com/biologics/bioxcel-therapeutics-files-chapter-11-eyes-teva-asset-sale2026-09-03T18:00Zyearly0.7 https://thebiotechtimes.com/biologics/crispr-therapeutics-ctx310-shows-durable-lipid-cuts-one-year2026-09-03T20:00Zyearly0.7 https://thebiotechtimes.com/biologics/eascra-biotech-wins-796m-nasa-contract-space-made-nanomedicine2026-09-04T14:00Zyearly0.7 https://thebiotechtimes.com/diagnostics/hvivo-acquires-crs-berlin-enter-dermatology-and-womens-health2026-08-29T16:24Zyearly0.7 https://thebiotechtimes.com/biologics/iba-swings-profit-h1-2026-proton-therapy-orders-surge2026-08-29T16:36Zyearly0.7 https://thebiotechtimes.com/diagnostics/heartflow-ffrct-cuts-unnecessary-heart-catheterisations-442026-09-04T16:00Zyearly0.7 https://thebiotechtimes.com/biologics/amarin-reduce-it-legacy-analysis-suggests-durable-cv-benefit-after-ipe2026-08-29T16:12Zyearly0.7 https://thebiotechtimes.com/diagnostics/philips-and-imricor-launch-combined-cardiac-imr-lab-solution2026-08-30T08:00Zyearly0.7 https://thebiotechtimes.com/diagnostics/quoin-pharmaceuticals-raises-50m-private-placement2026-09-03T16:00Zyearly0.7 https://thebiotechtimes.com/regulatory-science/quoin-pharmaceuticals-hits-interim-phase-23-endpoints-qrx0032026-09-07T14:00Zyearly0.7 https://thebiotechtimes.com/biologics/roche-vabysmo-shows-sustained-two-year-data-pcv-subtype-namd2026-08-30T05:00Zyearly0.7 https://thebiotechtimes.com/biologics/clinuvel-posts-tenth-consecutive-profit-cash-hits-a252m2026-09-08T18:00Zyearly0.7 https://thebiotechtimes.com/biologics/askbio-presents-genephit-phase-2-baseline-data-esc-20262026-09-01T12:30Zyearly0.7 https://thebiotechtimes.com/biologics/insulinova-partners-san-raffaele-test-encapsulated-beta-cells2026-09-01T08:00Zyearly0.7 https://thebiotechtimes.com/blossomhill-therapeutics-prices-upsized-150m-ipo-nasdaq2026-09-10T14:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/capsovision-posts-10-revenue-growth-ai-highlights-eyes-fda-clearance2026-09-09T20:00Zyearly0.7 https://thebiotechtimes.com/catheter-precision-lands-cardinal-health-deal-and-johns-hopkins-order2026-09-09T18:00Zyearly0.7 https://thebiotechtimes.com/biologics/cytokinetics-aficamten-data-show-structural-heart-benefits-hcm2026-08-31T14:53Zyearly0.7 https://thebiotechtimes.com/bioprocessing/pharmala-secures-mdma-patent-and-hires-canaccord-banking-partner2026-09-09T16:00Zyearly0.7 https://thebiotechtimes.com/biologics/tenax-therapeutics-presents-phase-3-level-data-esc-20262026-09-09T14:00Zyearly0.7 https://thebiotechtimes.com/regulatory-science/teva-bids-575m-bioxcel-dexmedetomidine-film-bankruptcy-sale2026-09-08T20:00Zyearly0.7 https://thebiotechtimes.com/bioprocessing/tomi-environmental-gains-ireland-bpr-approval-steramist2026-08-31T08:32Zyearly0.7 https://thebiotechtimes.com/biologics/acoramidis-shows-structural-cardiac-reversal-54-month-attr-cm-data2026-09-10T16:00Zmonthly0.7 https://thebiotechtimes.com/regulatory-science/artelo-biosciences-wins-us-patent-allowance-art2713-formulation2026-09-08T16:00Zyearly0.7 https://thebiotechtimes.com/diagnostics/autonomix-medical-secures-us-patent-feedback-guided-neuromodulation2026-09-08T14:00Zyearly0.7 https://thebiotechtimes.com/biologics/coloplast-reshuffles-elt-new-cpo-and-wound-unit-interim-lead2026-08-31T12:46Zyearly0.7 https://thebiotechtimes.com/biologics/coloplast-posts-6-organic-growth-q3-amid-biologics-drag2026-08-31T10:39Zyearly0.7 https://thebiotechtimes.com/digital-health/fangzhou-posts-22-revenue-rise-ai-chronic-care-push2026-09-01T05:00Zyearly0.7 https://thebiotechtimes.com/digital-health/globus-medical-acquires-duke-incubated-ai-firm-higgs-boson-health2026-09-07T20:00Zyearly0.7 https://thebiotechtimes.com/biologics/hutchmed-sanovo-trial-shows-pfs-gain-savolitinib-plus-osimertinib2026-08-31T08:46Zyearly0.7 https://thebiotechtimes.com/biologics/immuron-posts-record-a77m-fy26-sales-cdi-asset-heads-partner2026-08-31T08:32Zyearly0.7 https://thebiotechtimes.com/biologics/leios-therapeutics-licenses-10xb-101-cms-china-market2026-09-01T01:00Zyearly0.7 https://thebiotechtimes.com/diagnostics/trinity-biotech-faces-nasdaq-delisting-risk-amid-diagnostics-overhaul2026-09-01T10:15Zyearly0.7 https://thebiotechtimes.com/digital-health/leap-2026-opens-health-tech-fringe-ai-show2026-08-31T08:39Zyearly0.7 https://thebiotechtimes.com/biologics/alvotech-wins-fda-review-acceptance-avt80-vedolizumab-biosimilar2026-09-10T20:00Zmonthly0.7 https://thebiotechtimes.com/biologics/arch-biopartners-wins-irb-approval-open-us-sites-cs-aki-trial2026-09-11T14:00Zmonthly0.7 https://thebiotechtimes.com/biologics/ascendis-and-biomarin-settle-yuviwel-dispute-royalty-deal2026-09-11T16:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/beyond-air-wins-fda-breakthrough-device-tag-lungfit-go-ntm-pd2026-09-13T14:00Zmonthly0.7 https://thebiotechtimes.com/regulatory-science/cadrenal-therapeutics-gains-fda-alignment-cad-1005-phase-3-design2026-09-11T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/lecanemab-gets-positive-cda-amc-reimbursement-nod-canada2026-09-11T20:00Zmonthly0.7 https://thebiotechtimes.com/biologics/disc-medicine-present-first-disc-3405-clinical-data-soho-20262026-09-12T14:00Zmonthly0.7 https://thebiotechtimes.com/regulatory-science/inventiva-appoints-chris-benecchi-coo-ahead-mash-phase-3-readout2026-09-10T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/medera-srd-002-gene-therapy-hits-12-month-hfpef-endpoints2026-09-12T16:00Zmonthly0.7 https://thebiotechtimes.com/regulatory-science/palvella-completes-nda-submission-qtorin-rapamycin-gel-rare-lm2026-09-12T18:00Zmonthly0.7 https://thebiotechtimes.com/pmv-pharma-reports-46-orr-rezatapopt-ovarian-cancer-cohort2026-09-12T20:00Zmonthly0.7 https://thebiotechtimes.com/digital-health/xyra-doses-first-european-patient-budiodarone-af-trial2026-09-01T14:45Zyearly0.7 https://thebiotechtimes.com/digital-health/discovery-health-data-shows-women-lead-personal-health-pathways-uptake2026-09-02T07:00Zyearly0.7 https://thebiotechtimes.com/medical-devices/alpha-tau-completes-48-patient-impact-pancreatic-cancer-enrolment2026-09-02T10:15Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/biovie-completes-treatment-phase-bezisterim-long-covid-trial2026-09-13T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/boehringer-ingelheim-launches-scovella-equine-laminitis-gb2026-09-02T12:30Zyearly0.7 https://thebiotechtimes.com/diagnostics/intelligent-bio-solutions-hits-98-accuracy-ahead-510k-filing2026-09-13T18:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/junipers-jbs-003-wins-fda-breakthrough-therapy-designation2026-09-15T14:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/kala-bio-signs-loi-distribute-virotek-ophthalmic-genetic-tests2026-09-13T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/kyntra-bio-cuts-royalty-obligation-60m-balance-sheet-overhaul2026-09-14T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/novartis-remibrutinib-meets-phase-iii-endpoints-relapsing-ms2026-09-02T14:45Zyearly0.7 https://thebiotechtimes.com/cell-gene-therapy/ocugen-doses-first-patient-phase-3-gene-therapy-trial-dry-amd2026-09-14T16:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/telix-completes-bipass-enrolment-and-aligns-fda-nda-path2026-09-14T18:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/ultragenyx-publishes-96-week-phase-3-data-genglycos-gsdia2026-09-15T16:00Zmonthly0.7 https://thebiotechtimes.com/biologics/upstream-bio-plans-dual-phase-3-trials-verekitug-20272026-09-14T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/medtronic-raises-fy27-guidance-after-137-q1-revenue-growth2026-09-02T08:00Zyearly0.7 https://thebiotechtimes.com/medical-devices/aim-medical-robotics-wins-2m-nci-grant-mri-brain-robot2026-09-04T10:20Zyearly0.7 https://thebiotechtimes.com/biologics/attovia-therapeutics-raises-332m-ipo-itch-drug-shows-phase-1b-signal2026-09-15T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/hutchmed-licenses-kras-egfr-conjugate-hmpl-a830-gsk-13bn2026-09-05T10:15Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/inventiva-completes-patient-visits-nativ3-mash-phase-3-trial2026-09-04T10:20Zyearly0.7 https://thebiotechtimes.com/biologics/lecanemab-subcutaneous-autoinjector-approved-china-early-ad2026-09-05T01:00Zyearly0.7 https://thebiotechtimes.com/medical-devices/nyxoah-acccess-study-hits-safety-and-efficacy-endpoints-ccc-patients2026-09-04T10:20Zyearly0.7 https://thebiotechtimes.com/cell-gene-therapy/opus-genetics-unveil-opgx-best1-phase-12-data-9-september2026-09-04T10:20Zyearly0.7 https://thebiotechtimes.com/cell-gene-therapy/scribe-therapeutics-ipo-raises-155m-stx-1150-enters-clinic2026-09-04T10:20Zyearly0.7 https://thebiotechtimes.com/biologics/tevas-tev-408-meets-primary-endpoint-celiac-phase-2a2026-09-04T10:20Zyearly0.7 https://thebiotechtimes.com/biologics/transgene-tg4050-sustains-100-disease-free-survival-three-years2026-09-05T08:00Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/ultragenyx-phase-3-aspire-trial-fails-angelman-syndrome2026-09-17T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/canadas-cda-amc-backs-conditional-reimbursement-yorvipath2026-09-17T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/climb-bio-clym116-phase-1-data-back-every-12-week-dosing-igan2026-09-17T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/eledon-files-ind-islet-cell-transplant-trial-phase-3-nears2026-09-17T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/latigo-biotherapeutics-raises-397m-ipo-fund-non-opioid-pain-pipeline2026-09-16T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/newron-completes-enigma-trs-1-screening-12-week-data-due-q1-20272026-09-04T15:20Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/wuxi-tides-maps-path-oligonucleotides-beyond-liver2026-09-16T18:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/onward-medical-starts-eiger-implant-study-spinal-cord-injury2026-09-04T13:40Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/prf-technologies-clears-ind-ocuring-k-phase-ii-cataract-trial2026-09-16T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/stoke-and-biogen-present-4-year-zorevunersen-data-eec2026-09-16T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/tangram-therapeutics-advances-tgm-312-mash-patient-cohorts2026-09-04T10:20Zyearly0.7 https://thebiotechtimes.com/medical-devices/tensive-gets-eur20m-eib-loan-bioresorbable-breast-implant2026-09-04T12:00Zyearly0.7 https://thebiotechtimes.com/biologics/vaxcyte-hires-cmo-and-clo-vax-31-readout-moves-october2026-09-15T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/magrabi-health-earns-first-global-src-network-excellence2026-09-04T10:20Zyearly0.7 https://thebiotechtimes.com/medical-devices/biostems-vendaje-products-gain-vizient-and-premier-gpo-coverage2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/bioprocessing/cbak-energy-completes-nanjing-phase-ii-ramp-amid-96m-india-order2026-09-13T05:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/cosmos-health-posts-record-h1-revenue-369m-retires-debt-early2026-09-14T12:30Zmonthly0.7 https://thebiotechtimes.com/medical-devices/globus-medical-wins-ce-mark-excelsius3d-imaging-system-eu-and-uk2026-09-07T08:00Zyearly0.7 https://thebiotechtimes.com/cell-gene-therapy/intellia-therapeutics-secures-400m-debt-facility-orbimed2026-09-18T14:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/kala-bio-signs-exclusive-us-deal-virotek-eye-genetics-tests2026-09-20T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/novartis-pelacarsen-phase-iii-trial-fails-cut-cv-events2026-09-09T08:00Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/persica-pharmaceuticals-publishes-pkpd-case-pp353-back-pain2026-09-14T14:45Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/novartis-pelacarsen-trial-misses-primary-endpoint-lpa-study2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/tarsus-pharmaceuticals-completes-alkeus-buy-adds-stargardt-drug2026-09-24T14:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/wandercraft-signs-12-customers-calvin-40-industrial-humanoid2026-09-18T16:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/envetec-appoints-thermo-fisher-diagnostics-chief-board2026-09-18T18:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/envetec-wins-california-approval-generations-medical-waste-system2026-09-18T20:00Zmonthly0.7 https://thebiotechtimes.com/biologics/hcw-biologics-wins-patent-allowance-hcw9302-alopecia-areata2026-09-20T16:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/iba-joins-pfaros-consortium-test-electron-beam-pfas-destruction2026-09-15T08:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/lumexa-imaging-posts-q2-revenue-264m-advanced-volumes-rise2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/northstrive-biosciences-expands-ai-drug-discovery-pact-yuva2026-09-19T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/nxera-pharma-receive-86m-milestone-lilly-owned-centessa2026-09-19T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/oryzon-wins-us-patent-allowance-iadademstat-gilteritinib-aml-combo2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/medical-devices/philips-launches-fda-cleared-ev14-2v-single-transducer-obgyn2026-09-20T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/pmgc-holdings-signs-term-sheet-spaceflight-muscle-loss-study2026-09-19T18:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/szeged-treats-70-patients-first-month-robotic-cardiology2026-09-15T10:15Zmonthly0.7 https://thebiotechtimes.com/medical-devices/vivos-publishes-peer-reviewed-data-precisiongel-thermogel2026-09-19T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/american-shared-hospital-services-q2-revenue-rises-19-84m2026-09-20T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/baird-medical-swings-net-income-25-revenue-rise-h1-20262026-09-21T14:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/biomimetic-innovations-osstic-bone-filler-used-first-human-case2026-09-15T12:30Zmonthly0.7 https://thebiotechtimes.com/diagnostics/cytek-biosciences-showcase-spectral-cytometry-escca-and-iccs2026-09-24T16:00Zmonthly0.7 https://thebiotechtimes.com/digital-health/decent-holding-expands-china-elderly-care-network-623-centres2026-09-14T01:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/nexalin-reports-adas-cog-subscale-gains-ahead-alzheimers-pilot2026-09-21T16:00Zmonthly0.7 https://thebiotechtimes.com/digital-health/nokia-and-beehealthy-deploy-network-based-verification-healthcare2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/pulmovant-present-phase-2-phocus-topline-data-ers-20262026-09-21T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/roivant-unveil-mosliciguat-phase-2-ph-ild-data-ers-20262026-09-15T14:45Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/teva-achieves-full-investment-grade-status-after-sp-upgrade2026-09-21T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/silexion-therapeutics-prices-25m-offering-fund-sil204-trial2026-09-22T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/aprea-therapeutics-expands-patent-estate-wee1-and-atr-programmes2026-09-22T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/ascendis-present-infant-achondroplasia-data-espe-20262026-09-16T08:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/btt-medical-opens-first-human-trial-fever-induction-device2026-09-22T16:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/lakeland-fire-safety-wins-second-gfs-foul-weather-gear-contract2026-09-14T05:00Zmonthly0.7 https://thebiotechtimes.com/biologics/northstrive-files-patents-el-22-and-el-32-spaceflight-muscle-loss2026-09-22T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/novartis-harbor-phase-iii-trial-misses-primary-endpoint-dm12026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/novo-nordisk-semaglutide-clears-obesity-threshold-40-children2026-09-09T10:15Zyearly0.7 https://thebiotechtimes.com/medical-devices/nyxoah-enrols-first-patient-breathe-post-approval-osa-study2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/teva-launches-senior-notes-offering-refinance-existing-debt2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/biologics/vaxart-secures-european-patent-oral-norovirus-vaccine-platform2026-09-09T12:30Zyearly0.7 https://thebiotechtimes.com/genomics/ocearch-genomics-study-finds-sibling-pairs-among-white-sharks2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/zentalis-pharmaceuticals-launches-share-offering-azenosertib2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/airnexis-an01-meets-primary-endpoint-phase-2b-copd-study2026-09-23T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/apnimed-files-nda-osa-drug-oxnimbi-ahead-221m-nasdaq-ipo2026-09-25T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/assembly-bio-exercises-gilead-profit-share-option-hsv-drug-programme2026-09-23T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/bbot-reports-75-orr-bbo-8520-plus-pembrolizumab-2l-nsclc2026-09-25T18:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/brainchild-bio-closes-116m-series-fund-pivotal-dipg-car-t-trial2026-09-25T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/dyne-therapeutics-share-one-year-achieve-dm1-data-wms-and-aanem2026-09-23T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/korsana-biosciences-lists-nasdaq-after-380m-raise2026-09-25T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/monte-rosa-pockets-50m-milestone-novartis-starts-mrt-6160-phase-22026-09-13T08:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/pharvaris-hae-prophylaxis-trial-hits-83-attack-rate-reduction2026-09-10T10:32Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/roivants-mosliciguat-hits-phase-2-primary-endpoint-ph-ild2026-09-16T10:15Zmonthly0.7 https://thebiotechtimes.com/biologics/spyre-therapeutics-completes-ibd-proof-concept-spy003-data2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/biologics/vor-bio-completes-upstream-mg-enrolment-and-launches-omg-trial2026-09-23T20:00Zmonthly0.7 https://thebiotechtimes.com/biotech/sgu-and-taaleem-open-medical-school-pathways-uae-students2026-09-13T05:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/beeline-medicines-afimetoran-meets-phase-2-primary-endpoint-sle2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/biologics/disc-medicine-restore-pv-data-show-disc-3405-cut-phlebotomy-pv2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/ascendis-pharma-reports-52-week-infant-data-transcon-cnp-espe2026-09-10T10:31Zyearly0.7 https://thebiotechtimes.com/biologics/humacyte-wins-fda-nod-extend-symvess-shelf-life-36-months2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/impact-biotech-completes-enlighted-phase-3-padeliporfin-vtp2026-09-10T10:31Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/caspian-therapeutics-launches-50m-target-diabetes2026-09-10T10:31Zyearly0.7 https://thebiotechtimes.com/cell-gene-therapy/opus-genetics-reports-positive-phase-12-opgx-best1-data2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/bridgebio-propel-3-data-show-infigratinib-cuts-ear-infections2026-09-10T10:31Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/sobi-wins-fda-fast-track-pacritinib-vexas-syndrome2026-09-10T10:31Zyearly0.7 https://thebiotechtimes.com/biologics/solstice-oncology-launches-225m-series-ctla-4-antibody2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/biologics/sotio-doses-first-patient-cdh17-targeting-adc-trial-crc2026-09-10T10:31Zyearly0.7 https://thebiotechtimes.com/biologics/roche-wins-fda-priority-review-enspryng-mogad2026-09-10T10:31Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/giovanni-caforio-joins-cdr-operating-advisor-healthcare2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/adneuris-presents-phase-3-and-abuse-potential-data-cebranopadol2026-09-11T10:15Zmonthly0.7 https://thebiotechtimes.com/medical-devices/axogen-acquire-biocircuit-technologies-200m-cash2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/biologics/biora-therapeutics-start-first-human-trial-oral-biologic-capsule2026-09-24T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/cervomed-neflamapimod-nfvppa-biomarker-data-accepted-isftd-20262026-09-24T20:00Zmonthly0.7 https://thebiotechtimes.com/biologics/ethris-secures-eur30m-eib-loan-advance-mrna-antiviral-eth472026-09-13T10:15Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/imunon-signs-nci-crada-expand-imnn-001-new-solid-tumours2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/digital-health/instinct-science-launches-attending-ai-clinical-assistant-vets2026-09-11T10:15Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/legend-biotech-present-five-year-carvykti-data-ims-20262026-09-13T12:30Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/mannkind-and-rose-pharma-partner-inhaled-glp-1-weight-loss2026-09-11T10:15Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/medicus-pharma-selects-200-mg-skinject-dose-after-phase-2-bcc-readout2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/medical-devices/onward-medical-doubles-revenue-arc-ex-unit-sales-surge-4302026-09-11T10:15Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/optimi-health-launch-phase-2-psilocybin-trial-depression2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/medical-devices/health-textiles-nigeria-begins-permanet-dual-net-production2026-09-13T07:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/bionano-labs-ogm-test-line-medicare-coverage-under-proposed-lcd2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/camp4-therapeutics-wins-mhra-nod-cmp-002-syngap1-phase-12-trial2026-09-13T14:45Zmonthly0.7 https://thebiotechtimes.com/medical-devices/circle-cvi-positions-cvi42-tavr-volume-surge-after-cms-ruling2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/biologics/electra-therapeutics-starts-phase-1-sirpg-antibody-ela8222026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/pharming-wins-fda-approval-joenja-children-aged-4-11-apds2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/genomics/nad-recommends-nucleus-genomics-modify-embryo-screening-ad-claims2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/medical-devices/intuitive-meta-analysis-backs-da-vinci-across-13-conditions2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/nicox-ncx-470-nda-accepted-review-chinas-nmpa2026-09-13T01:00Zmonthly0.7 https://thebiotechtimes.com/agritech/rad-source-launches-sterile-insect-farms-division-mosquito-control2026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/resolution-therapeutics-completes-enrolment-emerald-liver-trial2026-09-14T08:00Zmonthly0.7 https://thebiotechtimes.com/biologics/syncromune-presents-sync-t-phase-1-prostate-data-cirse-20262026-09-12T17:33Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/teitur-trophics-reports-phase-i-safety-and-cns-exposure-tt-p342026-09-14T10:15Zmonthly0.7 https://thebiotechtimes.com/biotech/cannara-biotech-expands-credit-facility-c80m-bmo-and-td2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/diagnostics/cerenome-secures-20m-royalty-based-facility-scale-cnside-platform2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/medical-devices/coopercompanies-retains-coopersurgical-and-lifts-buyback-3bn2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/galimedix-present-edream-phase-2-ga-data-euretina-20262026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/biologics/genelux-publishes-sclc-case-report-showing-167-month-pfs-olvi-vec2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/medical-devices/hexiris-ophthalmics-show-obi-glaucoma-data-five-meetings2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/quantum-biopharma-clears-fda-ind-pad2-targeting-ms-drug-lucid-ms2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/biologics/immutep-refocuses-efti-hnscc-and-sarcoma-after-trial-failure2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/medical-devices/hope-therapeutics-first-deploy-zeta-surgicals-robotic-tms-system2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/rwb-acquires-controlling-stake-european-cannabis-platform2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/rhythm-pharma-setmelanotide-shows-bmi-gains-paediatric-ho-data2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/biologics/tam-peli-cuts-sclc-death-risk-54-phase-iii-roche-reports2026-09-13T16:46Zmonthly0.7 https://thebiotechtimes.com/medical-devices/axogen-prices-2087m-share-offering-fund-biocircuit-deal2026-09-26T14:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/femasys-partners-capexmd-finance-femaseed-fertility-access2026-09-27T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/wuxi-apptec-outlines-long-acting-oligonucleotide-manufacturing-hurdles2026-09-27T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/nanox-reports-37-revenue-rise-takes-407m-impairment-charge2026-09-26T16:00Zmonthly0.7 https://thebiotechtimes.com/biologics/oncolytics-reports-pelareorep-active-alongside-pan-ras-inhibitor-crc2026-09-26T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/persica-bolsters-pp353-rationale-disc-microbiology-review2026-09-16T14:45Zmonthly0.7 https://thebiotechtimes.com/diagnostics/chemometec-posts-3-revenue-rise-xcytomatic-sales-more-double2026-09-16T12:30Zmonthly0.7 https://thebiotechtimes.com/medical-devices/precision-optics-takes-13m-defence-follow-order-micro-optics2026-09-26T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/ss-innovations-reports-14000-procedures-and-telesurgery-record2026-09-17T08:00Zmonthly0.7 https://thebiotechtimes.com/digital-health/sequoia-project-ahima-and-hcpro-launch-information-blocking-training2026-09-27T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/verrica-present-ycanth-and-vp-315-data-two-dermatology-meetings2026-09-27T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/agomab-reports-positive-phase-1-data-inhaled-ipf-drug-agmb-4472026-09-17T10:15Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/curium-wins-fda-approval-bexlutry-lutetium-rlt-gep-nets2026-09-28T14:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/telixs-pixclara-wins-fda-approval-first-glioma-fet-pet-agent2026-09-28T16:00Zmonthly0.7 https://thebiotechtimes.com/biologics/immunocore-completes-tebe-am-enrolment-tebentafusp-phase-3-matures2026-09-17T12:30Zmonthly0.7 https://thebiotechtimes.com/biologics/jjs-amivantamab-plus-chemo-hits-34-month-os-egfr-ex20ins-nsclc2026-09-28T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/leios-therapeutics-clears-fda-end-phase-2-meeting-10xb-1012026-09-29T18:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/elixir-medical-wins-japan-approval-dynamx-coronary-bioadaptor2026-09-16T04:21Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/pharmazz-wins-fda-orphan-drug-designation-sovateltide-nhie2026-09-28T20:00Zmonthly0.7 https://thebiotechtimes.com/biologics/revelyx-bio-phase-2-data-back-recombinant-liquid-botulinum-toxin-yy0032026-09-29T14:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/tenaya-wins-fda-rmat-designation-arvc-gene-therapy-tn-4012026-09-29T20:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/veracyte-acquires-convergent-genomics-180m2026-09-29T16:00Zmonthly0.7 https://thebiotechtimes.com/biologics/leads-biolabs-opamtistomig-hits-87-orr-squamous-nsclc-wclc2026-09-16T06:40Zmonthly0.7 https://thebiotechtimes.com/medical-devices/magrabi-health-spotlights-centres-excellence-forbes-riyadh-summit2026-09-16T05:00Zmonthly0.7 https://thebiotechtimes.com/genomics/bionano-ogm-detects-hidden-genomic-risk-mds-and-aml-studies2026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/biovies-bezisterim-hits-subgroup-endpoints-phase-2-long-covid-trial2026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/blossomhills-bh-30643-hits-45-response-rate-c797s-nsclc2026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/biologics/connect-biopharmas-rademikibart-cuts-asthma-treatment-failure-662026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/dogwood-therapeutics-completes-enrolment-halneuron-cinp-phase-2b2026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/elevar-therapeutics-files-ema-application-lirafugratinib-cca2026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/ena-respiratory-begins-part-b-dosing-inna-051-phase-iia-study2026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/kestrel-therapeutics-wins-fda-fast-track-pan-kras-inhibitor-kst-60512026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/kortuc-hits-184-patient-enrolment-registrational-breast-cancer-trial2026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/biologics/one04-therapeutics-launches-phase-1-data-factor-h-candidate2026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/biologics/polaritybio-wins-fda-priority-review-skinte-bla-dfus2026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/biologics/vera-therapeutics-trutakna-cuts-igan-progression-risk-76-phase-32026-09-16T07:37Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/ascendis-pharma-regain-transcon-rights-metabolic-diseases2026-09-30T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/avacta-reports-clinical-proof-mechanism-ava6103-pdc-focus-012026-09-30T18:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/eib-and-angelini-ventures-hit-eur485m-deployed-under-eur150m-facility2026-09-17T14:51Zmonthly0.7 https://thebiotechtimes.com/medical-devices/flow-neuroscience-launches-fda-cleared-home-tdcs-device-fl-1002026-09-30T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/remedy-plan-advances-rpt1g-cohort-2-amlmds-phase-1-trial2026-09-17T08:22Zmonthly0.7 https://thebiotechtimes.com/biologics/roches-lunsumio-plus-lenalidomide-meets-phase-iii-pfs-endpoint-fl2026-09-18T08:00Zmonthly0.7 https://thebiotechtimes.com/digital-health/nightware-wearable-cuts-nightmare-distress-first-responder-study2026-10-01T18:00Zmonthly0.7 https://thebiotechtimes.com/proteomics/seer-hits-100-peer-reviewed-publications-proteograph-platform2026-10-01T14:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/senseonics-partners-beta-bionics-link-eversense-365-ilet2026-10-01T16:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/sonus-microsystems-and-medtronic-partner-ai-wearable-preeclampsia2026-09-17T08:24Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/tempest-therapeutics-options-senlang-lentiviral-vivo-car-t-platform2026-09-17T08:22Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/x-chem-wins-chordoma-foundation-tbxt-challenge-novel-binder2026-09-17T08:22Zmonthly0.7 https://thebiotechtimes.com/biotech/anew-labs-raises-290m-15bn-valuation-ai-drug-discovery2026-09-17T08:24Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/rws-launches-tridion-agentic-platform-regulated-content-workflows2026-09-30T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/1st-bio-and-sk-biopharma-ink-3148m-parkinsons-licence-1st-1042026-09-21T06:00Zmonthly0.7 https://thebiotechtimes.com/biologics/nccn-guidelines-name-clonoseq-myeloma-mrd-testing2026-09-22T00:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/aquestive-resubmits-anaphylm-nda-after-human-factors-and-pk-studies2026-09-21T06:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/capricor-present-24-month-deramiocel-dmd-data-wms-20262026-09-21T05:40Zmonthly0.7 https://thebiotechtimes.com/biologics/lisata-therapeutics-acquires-marea-and-raises-225m-concurrent-pipe2026-09-24T00:00Zmonthly0.7 https://thebiotechtimes.com/biologics/novo-nordisk-wins-chmp-nod-denecimig-haemophilia2026-09-21T14:45Zmonthly0.7 https://thebiotechtimes.com/biologics/biogen-publishes-phase-3-empaveli-paediatric-data-cjasn2026-09-23T00:00Zmonthly0.7 https://thebiotechtimes.com/biologics/snipr-enrolls-first-phase-2-patient-crispr-phage-trial2026-09-21T06:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/sol-gel-hits-lplv-milestone-phase-3-gorlin-syndrome-trial2026-09-23T00:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/ultragenyx-wins-fda-approval-fayuvi-sanfilippo-syndrome-type2026-09-21T06:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/umethod-health-publishes-real-world-study-ai-dementia-care-plans2026-09-22T00:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/wandercraft-launches-eve-self-balancing-exoskeleton-home-use2026-09-21T06:00Zmonthly0.7 https://thebiotechtimes.com/agritech/tanmiah-opens-rd-innovation-center-riyadh-headquarters2026-09-21T05:37Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/blossomhill-raises-168m-ipo-and-wins-fda-fast-track-bh-306432026-09-26T00:00Zmonthly0.7 https://thebiotechtimes.com/biologics/jjs-teclistamab-wins-chmp-backing-second-line-myeloma-use2026-09-22T08:00Zmonthly0.7 https://thebiotechtimes.com/biologics/roches-ocrevus-gets-chmp-backing-paediatric-ms2026-09-22T10:15Zmonthly0.7 https://thebiotechtimes.com/diagnostics/conavi-medical-publishes-hybrid-ivus-oct-case-report-cci2026-09-25T00:00Zmonthly0.7 https://thebiotechtimes.com/biologics/electra-therapeutics-prices-upsized-350m-ipo-nasdaq2026-09-24T00:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/mira-pharmaceuticals-submits-ketamir-2-phase-2a-protocol-cipn2026-09-21T05:37Zmonthly0.7 https://thebiotechtimes.com/biologics/novartis-secukinumab-gets-positive-chmp-opinion-pmr2026-09-21T08:00Zmonthly0.7 https://thebiotechtimes.com/biologics/novo-nordisks-sogroya-wins-chmp-backing-idiopathic-short-stature2026-09-21T10:15Zmonthly0.7 https://thebiotechtimes.com/biologics/bavarian-nordic-appoints-tarja-stenvall-ceo-october2026-09-22T14:45Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/teva-presents-phase-3-data-once-monthly-olanzapine-lai-tev-7492026-10-02T14:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/treace-medical-reports-5-year-lapiplasty-data-aofas-20262026-10-02T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/zealand-pharma-gets-chmp-nod-glepaglutide-short-bowel-syndrome2026-09-22T12:30Zmonthly0.7 https://thebiotechtimes.com/medical-devices/avava-raises-45m-scale-focal-point-technology-aesthetics-platform2026-10-02T18:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/biostem-technologies-secures-40m-committed-equity-facility-roth2026-10-02T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/cardiff-oncology-and-nms-settle-dispute-and-expand-onvansertib-deal2026-10-03T14:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/coopercompanies-posts-107bn-q3-revenue-amid-cvi-inventory-drag2026-10-03T16:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/firefly-neuroscience-evoke-platform-join-radials-ai-clinical-os2026-10-03T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/goa-therapeutics-exits-stealth-155m-alcohol-antidote2026-10-03T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/jack-ady-cancer-centre-launches-albertas-first-rural-cancer-trial2026-10-04T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/rezera-launches-reveal-pad-study-map-inflammation-pad2026-10-04T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/syneos-health-and-tufts-csdd-study-finds-no-superior-cro-model2026-10-04T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/tiziana-life-sciences-signs-kaimrc-mou-rrms-combination-trial2026-09-21T09:20Zmonthly0.7 https://thebiotechtimes.com/digital-health/ultrahuman-merges-ring-data-medical-records-healthex2026-10-04T20:00Zmonthly0.7 https://thebiotechtimes.com/biologics/vivosim-labs-presents-namkind-toxicity-data-eurotox-20262026-09-21T06:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/avai-bio-clears-cell-bank-safety-testing-klotho-therapy2026-09-22T06:47Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/cdt-equity-and-qima-test-tapinarof-combos-psoriasis2026-10-05T16:00Zmonthly0.7 https://thebiotechtimes.com/biologics/cue-biopharma-cue-221-beats-placebo-and-omalizumab-csu-trial2026-09-22T07:54Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/longeveron-hlhs-stem-cell-trial-misses-primary-endpoint2026-09-22T06:47Zmonthly0.7 https://thebiotechtimes.com/medical-devices/milestone-scientific-adds-pain-and-spine-compuflo-programme2026-09-22T06:47Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/teva-study-shows-hcps-favour-austedo-attributes-older-td-patients2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/medical-devices/philips-wins-two-itea-2026-awards-ai-enabled-healthcare-projects2026-09-21T12:30Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/roche-opens-boston-cvrm-hub-harvard-campus-part-50bn-us-push2026-10-01T20:00Zmonthly0.7 https://thebiotechtimes.com/diagnostics/spectral-ai-showcases-deepview-burn-diagnostic-srbc2026-09-22T06:47Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/telix-acquire-itm-165bn-radiopharmaceutical-deal2026-09-24T14:45Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/telomir-pharmaceuticals-publishes-preclinical-amd-data-telomir-zn2026-09-22T06:47Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/tevas-uzedy-shows-lower-er-visits-and-cost-savings-real-world-data2026-10-06T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/roche-enicepatide-hits-both-phase-ii-endpoints-t2d-and-obesity2026-09-24T12:30Zmonthly0.7 https://thebiotechtimes.com/biologics/anaptysbio-reports-jemperli-royalties-34-fda-decision-looms2026-09-22T06:47Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/avalyn-publishes-phase-1-data-showing-ap02s-lung-targeted-delivery2026-10-06T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/hmnc-brain-health-names-doebler-ceo-ahead-phase-3-push2026-09-24T10:15Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/jj-wins-ec-approval-icotrokinra-plaque-psoriasis2026-09-24T08:00Zmonthly0.7 https://thebiotechtimes.com/biologics/roche-wins-ec-approval-susvimo-refillable-eye-implant-namd2026-09-23T14:45Zmonthly0.7 https://thebiotechtimes.com/digital-health/kfsh-named-saudi-arabias-most-valuable-healthcare-brand2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/biologics/leads-biolabs-secures-esmo-2026-lba-slot-ep-nec-pivotal-data2026-09-22T06:48Zmonthly0.7 https://thebiotechtimes.com/digital-health/new-era-energy-inks-20-year-207-mw-power-deal-vistra2026-10-05T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/newamsterdam-and-menarini-win-ec-approval-obicetrapib2026-09-23T12:30Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/novo-nordisk-cagrisema-beats-tirzepatide-weight-loss-phase-32026-09-23T10:15Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/vironexis-vnx-101-achieves-mrd-negative-responses-rr-all2026-10-05T18:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/z-optics-presents-six-month-iol-data-escrs-20262026-09-23T08:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/fakih-ivf-marks-uae-15th-anniversary-free-ivf-initiative2026-09-22T06:48Zmonthly0.7 https://thebiotechtimes.com/biotech/patient-safety-checklist-marks-25-years-reform-agenda-unfinished2026-10-05T14:00Zmonthly0.7 https://thebiotechtimes.com/biologics/adagene-wins-nmpa-ind-clearance-masked-her2xcd3-bispecific-adg1382026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/biologics/atcc-wins-99m-dow-contract-manage-military-medical-countermeasures2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/addex-therapeutics-posts-chf-67m-net-loss-cash-falls-chf-16m2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/biologics/celldex-barzolvolimab-phase-3-trials-meet-all-endpoints-csu2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/medical-devices/dialybrid-raises-eur15m-series-and-achieves-first-human-implant2026-09-29T10:15Zmonthly0.7 https://thebiotechtimes.com/biologics/eledon-tegoprubart-shows-13-mlmin-egfr-edge-over-tacrolimus2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/biologics/envisagenics-and-boehringer-ingelheim-1bn-rna-splicing-deal2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/filana-therapeutics-clears-fda-hold-simufilam-tsc-epilepsy2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/ophirex-bravio-trial-misses-endpoints-signals-krait-benefit2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/biologics/pds-biotechs-pds0101-combo-shows-39-month-survival-hnscc-trial2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/quoin-pharma-wins-fda-fast-track-qrx003-peeling-skin-syndrome2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/medical-devices/traferox-xdegport-heart-wins-fda-510k-clearance-transplant-use2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/zealand-pharma-starts-phase-3-zupreme-programme-petrelintide2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/annovis-bio-publishes-phase-23-buntanetap-alzheimers-data-nature2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/actimed-therapeutics-completes-proact-phase-2a-recruitment2026-09-29T12:30Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/actinogen-xanamia-alzheimers-trial-completes-visits-data-due-november2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/diagnostics/adaptyx-wins-fda-breakthrough-device-tag-cortisol-monitor2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/medical-devices/anaconda-biomed-closes-56m-round-fund-stroke-thrombectomy-trial2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/crossject-and-barda-align-zepizure-paediatric-plan-fda2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/elevar-therapeutics-wins-fda-approval-lyrfigtu-bile-duct-cancer2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/hutchmed-takes-savolitinib-osimertinib-combo-esmo-20262026-09-29T14:45Zmonthly0.7 https://thebiotechtimes.com/diagnostics/phast-corp-wins-fda-clearance-rapid-blood-culture-ast-panel2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/roche-sefaxersen-hits-phase-iii-primary-endpoint-iga-nephropathy2026-09-30T08:00Zmonthly0.7 https://thebiotechtimes.com/biologics/scarlet-therapeutics-wins-14m-darpa-deal-smart-red-blood-cells2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/avalyn-pharma-raises-300m-nasdaq-ipo-fibrosis-drugs2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/biologics/sotio-wins-dual-fda-designations-adc-sot106-sarcoma2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/roquette-posts-9-revenue-growth-h1-2026-pharma-excipient-gains2026-09-30T10:15Zmonthly0.7 https://thebiotechtimes.com/biologics/atyr-pharma-secures-fda-alignment-efzofitimod-phase-3-design2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/elicio-therapeutics-amplify-7p-data-selected-esmo-2026-oral-slot2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/biologics/imunon-reports-147-month-os-gain-phase-2-ovarian-cancer-trial2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/ligand-commits-47m-back-avencells-allogeneic-car-t-pipeline2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/medicinova-completes-double-blind-phase-combat-als-ibudilast-trial2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/nuvectis-nxp200-wins-breakthrough-therapy-designation-china-hgg2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/medical-devices/precision-neuroscience-closes-250m-series-d-bci-expansion2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/prime-medicine-wins-fda-ind-clearance-pm647-aatd2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/bioprocessing/cabaletta-bio-signs-10-year-cell-therapy-supply-deal-cellares2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/biologics/rezolutes-ersodetug-shows-strong-interim-data-tumour-hi-trial2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/satellos-wins-fda-ind-clearance-forazapadin-fshd2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/biologics/scancell-secures-25m-blackrock-debt-facility-fund-iscib1-phase-32026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/biologics/transgene-reports-100-dfs-41-months-tg4050-hnscc-vaccine2026-09-28T10:15Zmonthly0.7 https://thebiotechtimes.com/diagnostics/adaptive-biotechnologies-cites-clonoseq-new-myeloma-cure-definition2026-09-28T12:30Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/adarx-pharmaceuticals-prices-446m-ipo-nasdaq2026-10-09T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/addex-regains-global-gabab-pam-rights-after-indivior-rd-pullback2026-09-28T14:45Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/avacta-presents-focus-01-trial-design-and-ava6103-pdac-data-aacr2026-10-10T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/ec-approves-leriglitazone-first-pharmacological-cald-treatment2026-09-29T08:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/firefly-and-neurosigma-partner-distribute-fda-cleared-adhd-device2026-10-06T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/quoin-pharma-maps-multi-indication-clinical-push-qrx009-rapamycin2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/digital-health/knowtex-named-prime-awardee-vas-775m-ambient-scribe-contract2026-10-10T16:00Zmonthly0.7 https://thebiotechtimes.com/proteomics/alamar-biosciences-platform-underpins-lancet-neurology-lecanemab-study2026-10-10T18:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/carvykti-half-earlier-line-myeloma-patients-free-five-years2026-10-10T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/nanobiotix-reports-nbtxr3-nsclc-data-and-eur86m-raise2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/pharming-wins-fda-priority-review-joenja-lighter-children2026-09-27T18:20Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/carvykti-gives-five-year-remissions-50-early-line-myeloma2026-09-28T08:00Zmonthly0.7 https://thebiotechtimes.com/biologics/absci-plans-phase-2-storyline-trial-abs-201-endometriosis2026-10-09T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/c4-therapeutics-cemsidomide-shows-t-cell-data-ims-20262026-10-09T16:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/celularity-closes-10m-first-tranche-28m-recapitalisation2026-10-09T14:00Zmonthly0.7 https://thebiotechtimes.com/digital-health/chrysalis-health-and-curaechoice-partner-no-cost-mental-health-access2026-10-08T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/cortec-bci-implant-enables-stroke-patient-control-computer-thought2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/cell-gene-therapy/cirm-awards-9m-enloe-health-northern-california-cgt-centre2026-10-08T18:00Zmonthly0.7 https://thebiotechtimes.com/synthetic-biology/kraig-biocraft-completes-atlas-gene-library-silkworm-hosts2026-10-08T16:00Zmonthly0.7 https://thebiotechtimes.com/biologics/medicenna-present-bizaxofusp-rgbm-survival-data-sno-20262026-10-08T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/milestone-pharma-enrols-first-canadian-patient-afib-rvr-trial2026-10-07T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/neurocare-and-wave-neuroscience-partner-eeg-guided-ptsd-therapy2026-10-07T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/newrons-enigma-trs-2-us-enrolment-hold-stays-ex-us-sites-expand2026-10-07T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/pridcor-therapeutics-advances-phase-2-shield-long-covid-study2026-10-06T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/vistagen-sees-fasedienol-signal-severe-social-anxiety2026-10-07T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/addex-therapeutics-posts-h1-2026-loss-cash-falls-chf-08m2026-09-30T14:45Zmonthly0.7 https://thebiotechtimes.com/biologics/annexon-present-archer-ii-baseline-data-retina-society-meeting2026-09-29T14:43Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/creative-medical-claims-93-response-rate-ultrasome-knee-oa-pilot2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/cell-gene-therapy/avai-bio-and-austrianova-present-klothonova-encapsulated-cell-data2026-09-29T14:43Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/boehringer-ingelheim-funds-who-foundation-obesity-drive-5m2026-10-01T12:30Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/crossject-strengthens-balance-sheet-barda-deal-extended-48m2026-10-01T10:15Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/crossject-expands-board-and-hires-ex-fda-lead-ahead-zepizure-launch2026-10-02T08:00Zmonthly0.7 https://thebiotechtimes.com/digital-health/ingenio-care-launches-ai-enabled-national-healthcare-marketplace2026-09-29T14:43Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/itm-reports-re-treatment-and-dosimetry-data-itm-11-astro2026-09-29T14:43Zmonthly0.7 https://thebiotechtimes.com/medical-devices/kessler-foundation-and-upnride-partner-upright-mobility-study2026-09-29T14:43Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/ocugens-ocu400-gains-provisional-approval-bahamas-rp2026-09-29T14:43Zmonthly0.7 https://thebiotechtimes.com/medical-devices/penn-medicine-and-iba-form-noventra-oncology-alliance-jv2026-10-01T08:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/4dmt-enrols-first-patients-4sight-phase-3-dme-gene-therapy-trial2026-10-11T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/crescent-biopharma-posts-q1-2026-results-189m-cash-runway2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/biologics/alx-oncologys-evorpacept-hits-636-orr-her2-gastric-subgroup2026-10-12T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/belite-bio-present-dragon-phase-3-tinlarebant-data-euretina2026-10-01T14:45Zmonthly0.7 https://thebiotechtimes.com/medical-devices/capsovision-wins-fda-clearance-ai-highlights-capsule-endoscopy-tool2026-10-12T18:00Zmonthly0.7 https://thebiotechtimes.com/agritech/cibus-and-crystal-crop-partner-gene-edit-indias-mustard-crop2026-09-30T01:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/currus-biologics-wins-fda-ind-clearance-cur-001-car-t-trial2026-10-12T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/hutchmed-files-us-nda-savolitinib-plus-osimertinib-nsclc2026-10-12T14:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/iba-install-first-gantry-proton-therapy-centre-central-italy2026-09-30T12:30Zmonthly0.7 https://thebiotechtimes.com/bioprocessing/lifecore-biomedical-go-private-664m-webster-equity-deal2026-10-11T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/oryzon-secures-ema-approval-start-hope-2-vafidemstat-trial-pms2026-10-02T10:15Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/scynexis-wins-214m-barda-contract-develop-scy-247-antifungal2026-10-11T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/cristcot-present-cessa-corticosteroid-data-ddw-20262026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/biologics/teva-wins-fda-approval-degevma-denosumab-biosimilar-xgeva2026-10-11T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/beyondspring-wins-fast-track-plinabulin-post-ici-nsclc2026-10-23T18:00Zweekly0.7 https://thebiotechtimes.com/pharmaceuticals/cellectar-present-phase-2-wm-subset-data-iwwm-20262026-10-23T14:00Zweekly0.7 https://thebiotechtimes.com/biologics/dbv-technologies-files-bla-fda-viaskin-peanut-patch2026-10-26T16:00Zweekly0.7 https://thebiotechtimes.com/cell-gene-therapy/immix-biopharma-nxc-201-hits-89-cr-rate-al-amyloidosis-trial2026-10-26T14:00Zweekly0.7 https://thebiotechtimes.com/biologics/invivyds-vyd2311-beats-mrna-vaccine-safety-phase-3-liberty-study2026-10-25T20:00Zweekly0.7 https://thebiotechtimes.com/biologics/knight-therapeutics-signs-latin-america-deal-kyowa-kirins-poteligeo2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/novo-nordisk-licenses-hengruis-oral-glp-1gip-agonist-26bn2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/biologics/polaritybio-phase-3-dfu-data-wins-first-podium-slot-sawc-20262026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/roche-fenebrutinib-nda-accepted-fda-rms-and-ppms2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/greenwich-lifesciences-delays-10-k-amid-flamingo-01-data-update2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/biologics/tectonic-therapeutic-reports-clean-phase-1a-data-hht-drug2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/uniqure-amt-130-shows-80-disease-slowing-36-months-hd-trial2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/zealand-pharma-petrelintide-hits-107-weight-loss-phase-22026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/diagnostics/hub71-and-unilabs-partner-bring-diagnostics-abu-dhabi-startups2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/digital-health/dardoc-launches-truesight-beta-ai-layer-inside-lifestyle-rx-platform2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/atsenas-atsn-201-shows-durable-xlrs-benefit-18-months2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/biologics/candel-reports-durable-immune-remodelling-data-aglatimagene2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/medical-devices/ceribell-wins-fda-clearance-qeeg-trending-its-ai-platform2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/biologics/connect-biopharma-rademikibart-cuts-copd-failure-rate-81-ph22026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/biologics/egle-therapeutics-egl-003-phase-1-shows-clean-safety-treg-lift2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/innocare-doses-first-patient-phase-iii-orelabrutinib-sle-trial2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/highlight-therapeutics-bo-112-meets-phase-2b-bcc-endpoint2026-10-14T08:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/integer-holdings-clears-us-antitrust-hurdle-57bn-kkr-buyout2026-10-25T18:00Zweekly0.7 https://thebiotechtimes.com/cell-gene-therapy/mink-therapeutics-joins-arpa-h-boss-room-temperature-cell-therapy-push2026-10-25T16:00Zweekly0.7 https://thebiotechtimes.com/pharmaceuticals/moleculin-biotech-completes-part-enrolment-aml-miracle-trial2026-10-25T14:00Zweekly0.7 https://thebiotechtimes.com/pharmaceuticals/novo-nordisk-cagrisema-data-shows-brain-organ-and-bone-effects2026-10-13T14:45Zmonthly0.7 https://thebiotechtimes.com/biologics/regeneron-and-sanofi-expand-antibody-alliance-8bn-deal2026-10-26T18:00Zweekly0.7 https://thebiotechtimes.com/digital-health/uvm-wins-38m-arpa-h-contract-build-ai-digital-twins-icu-care2026-10-24T20:00Zweekly0.7 https://thebiotechtimes.com/pharmaceuticals/boehringers-survodutide-hits-phase-iii-endpoints-obesity-plus-t2d2026-10-13T12:30Zmonthly0.7 https://thebiotechtimes.com/biologics/candel-therapeutics-publishes-phase-2a-nsclc-data-showing-245-month-mos2026-10-24T18:00Zweekly0.7 https://thebiotechtimes.com/pharmaceuticals/polypids-d-plex100-maa-validated-ema-ssi-prevention2026-10-13T10:15Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/kestrel-therapeutics-doses-first-patient-falcon-pan-kras-trial2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/trethera-wins-fda-fast-track-tre-515-kras-g12c-nsclc2026-10-24T16:00Zweekly0.7 https://thebiotechtimes.com/pharmaceuticals/monte-rosa-mrt-8102-phase-1-data-show-ascvd-biomarker-normalisation2026-10-24T14:00Zweekly0.7 https://thebiotechtimes.com/biologics/regenerons-trevogrumab-preserves-muscle-during-semaglutide-weight-loss2026-10-23T20:00Zweekly0.7 https://thebiotechtimes.com/biologics/sanofi-and-regeneron-expand-immunology-alliance-8bn-deal2026-10-13T08:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/roche-giredestrant-cuts-progression-risk-44-breast-cancer-trial2026-10-13T06:03Zmonthly0.7 https://thebiotechtimes.com/medical-devices/si-bone-wins-fda-510k-ifuse-granite-onyx-spinal-screw-system2026-10-23T16:00Zweekly0.7 https://thebiotechtimes.com/biologics/regenerons-ubamatamab-hits-73-response-rate-lgsoc-trial2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/medical-devices/wandercraft-acquires-ekso-bionics-form-global-exoskeleton-leader2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/survodutide-hits-131-weight-loss-phase-iii-obesity-t2d-trial2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/discovery-vitality-adds-doctor-led-glp-1-pathway-weight-programme2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/mesoblast-completes-enrolment-phase-3-chronic-back-pain-trial2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/amplio-pharma-phase-1b-data-back-novobioject-methotrexate-booster2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/artiva-present-allonk-autoimmune-data-across-34-patients-acr-20262026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/biologics/biogen-litifilimab-cle-data-show-durable-skin-clearance-52-weeks2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/century-therapeutics-cnty-813-hits-ind-readiness-milestones-easd2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/ema-validates-biosplices-lorecivivint-application-knee-oa2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/medical-devices/iba-distribute-artms-qis-cyclotron-technology-theranostics2026-10-13T14:00Zmonthly0.7 https://thebiotechtimes.com/biologics/leads-biolabs-opamtistomig-wins-japan-orphan-status-ep-nec2026-10-09T05:29Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/cullinan-files-nda-zipalertinib-first-line-egfr-ex20ins-nsclc2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/novo-semaglutide-data-show-liver-fat-normalised-88-obese-adults2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/teva-ecopipam-shows-durable-tic-reduction-tourette-trial2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/nicox-cuts-net-loss-eur24m-ncx-470-nda-filing-nears2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/medical-devices/vicentra-kaleido-patch-pump-hits-tir-targets-3918-patient-study2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/biologics/viromissile-clears-first-cohort-iv-dosed-oncolytic-virus-phase-i2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/samfara-acquires-chr-olesen-synthesis-controlled-substance-api-deal2026-10-09T05:28Zmonthly0.7 https://thebiotechtimes.com/medical-devices/autonomix-medical-secures-fda-support-510k-sensing-platform2026-10-15T20:00Zmonthly0.7 https://thebiotechtimes.com/biologics/climb-bio-show-phase-2-budoprutug-and-clym116-data-asn-20262026-10-15T18:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/elutia-receives-8m-boston-scientific-escrow-funded-20292026-10-13T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/gain-therapeutics-rexaceract-holds-motor-scores-stable-12-months2026-10-13T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/genmabs-rina-s-hits-46-response-rate-proc-trial2026-10-15T16:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/inspire-medical-wins-new-cpt-codes-its-inspire-v-device2026-10-15T14:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/integra-lifesciences-cuts-2026-guidance-after-cincinnati-flood2026-10-14T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/ocular-therapeutix-enrols-first-patient-sol-x-wet-amd-extension-trial2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/pharmaceuticals/liquidia-loses-patent-ruling-yutrepia-ph-ild-indication2026-10-14T18:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/mink-therapeutics-show-inkt-cell-data-sitc-20262026-10-14T16:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/nexalin-technology-signs-10-year-south-america-distribution-deal2026-10-09T12:00Zmonthly0.7 https://thebiotechtimes.com/biologics/novo-nordisks-denecimig-bla-delayed-manufacturing-site-remediation2026-10-13T16:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/spyglass-pharma-buys-avs-13m-lock-iol-supply2026-10-14T14:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/aavantgarde-sees-early-efficacy-signals-dual-aav-eye-therapy2026-10-09T08:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/car-t-safety-events-dent-rheumatologist-confidence-spherix-finds2026-10-16T14:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/avai-bio-and-austrianova-confirm-klotho-secretion-encapsulated-cells2026-10-16T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/cuprina-acquire-seven-clinic-singapore-healthcare-group-s4m2026-10-09T07:15Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/dare-bioscience-patents-lopinavir-ritonavir-insert-hpv-clearance2026-10-17T14:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/telix-optimal-psma-dosimetry-data-back-tlx597-tx-dose-push2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/cell-gene-therapy/ernexa-therapeutics-names-spiegel-board-ahead-erna-101-ind2026-10-16T16:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/immix-biopharma-prices-125m-share-offering-fund-nxc-2012026-10-17T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/tevas-ecopipam-review-highlights-d1-receptor-edge-tourette-tics2026-10-17T18:00Zmonthly0.7 https://thebiotechtimes.com/biologics/northstrive-biosciences-engages-charles-river-probiotic-cro-work2026-10-16T18:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/prokidney-present-eight-rilparencel-abstracts-asn-kidney-week-20262026-10-17T20:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/psyence-biomed-secures-exclusive-us-ibogaine-licence-texas-unit2026-10-18T14:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/teknova-and-pluristyx-file-fda-drug-master-file-plurifreeze2026-10-18T16:00Zmonthly0.7 https://thebiotechtimes.com/biologics/alector-licenses-al050-gcase-therapy-genentech-127bn2026-10-19T16:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/assembly-bio-reports-phase-1a-safety-win-ntcp-inhibitor-abi-62502026-10-19T18:00Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/bridgebio-bbp-418-shows-cardiac-biomarker-normalisation-lgmd2ir92026-10-19T20:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/orchard-therapeutics-wins-innovation-passport-otl-201-mps-iiia2026-06-30T11:48Zyearly0.7 https://thebiotechtimes.com/cell-gene-therapy/capricor-dmd-cell-therapy-data-show-76-upper-limb-decline-slowdown2026-10-20T14:00Zmonthly0.7 https://thebiotechtimes.com/biologics/epcoritamab-plus-r-chop-cuts-dlbcl-progression-risk-51-phase-32026-10-09T10:15Zmonthly0.7 https://thebiotechtimes.com/pharmaceuticals/harrow-closes-30m-tyrvaya-acquisition-viatris2026-10-18T20:00Zmonthly0.7 https://thebiotechtimes.com/medical-devices/irhythm-completes-2375m-vitalconnect-acquisition2026-10-20T16:00Zmonthly0.7 https://thebiotechtimes.com/biologics/oncusp-cusp06-hits-62-response-rate-resistant-ovarian-cancer2026-10-19T14:00Zmonthly0.7 https://thebiotechtimes.com/cell-gene-therapy/prime-medicine-doses-first-patient-pm577a-wilson-disease-trial2026-10-20T18:00Zmonthly0.7